As part of Dexcom’s G6 system, trend lines on smart devices show where glucose levels are heading. The company is working on next-generation glucose monitoring with Verily. Photo courtesy of Dexcom

As part of Dexcom’s G6 system, trend lines on smart devices show where glucose levels are heading. The company is working on next-generation glucose monitoring with Verily. Photo courtesy of Dexcom

San Diego’s Dexcom will pay $250 million in stock to Verily — a subsidiary of Google parent company Alphabet — as part of an amended deal...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129